These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12081637)

  • 21. Determinants of prescribing costs amongst single-handed general practitioners.
    Gill PS; Roalfe A
    J Clin Pharm Ther; 2001 Dec; 26(6):433-5. PubMed ID: 11722680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do NHS GP surgeries employing GPs additionally trained in integrative or complementary medicine have lower antibiotic prescribing rates? Retrospective cross-sectional analysis of national primary care prescribing data in England in 2016.
    van der Werf ET; Duncan LJ; Flotow PV; Baars EW
    BMJ Open; 2018 Mar; 8(3):e020488. PubMed ID: 29555793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource.
    Pollock K; Grime J
    Soc Sci Med; 2000 Dec; 51(12):1827-39. PubMed ID: 11128270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of prescribing unit with index including both age and sex in assessing general practice prescribing costs.
    Purves IN; Edwards C
    BMJ; 1993 Feb; 306(6876):496-8. PubMed ID: 8448463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Working together: a qualitative study of effective group formation amongst GPs during a cost-driven prescribing initiative.
    Walker J; Mathers N
    Fam Pract; 2004 Oct; 21(5):552-8. PubMed ID: 15367478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savings.
    Littman J; Halil R
    Can Fam Physician; 2016 Mar; 62(3):235-44. PubMed ID: 26975917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescribing behaviour in general practice: the impact of promoting therapeutically equivalent cheaper medicines.
    Roberts SJ; Bateman DN; Smith JM
    Br J Gen Pract; 1997 Jan; 47(414):13-8. PubMed ID: 9115786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving the appropriateness of physician prescribing.
    Lexchin J
    Int J Health Serv; 1998; 28(2):253-67. PubMed ID: 9595343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
    Caudill TS; Johnson MS; Rich EC; McKinney WP
    Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving antimicrobial prescribing in Irish primary care through electronic data collection and surveillance: a feasibility study.
    Galvin S; Callan A; Cormican M; Duane S; Bennett K; Murphy AW; Vellinga A
    BMC Fam Pract; 2015 Jul; 16():77. PubMed ID: 26135455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Appropriate prescribing in asthma and its related cost in east London.
    Naish J; Sturdy P; Toon P
    BMJ; 1995 Jan; 310(6972):97-100. PubMed ID: 7833736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating prescribing interventions.
    Wong G
    Br J Gen Pract; 2002 May; 52(478):412-3. PubMed ID: 12014546
    [No Abstract]   [Full Text] [Related]  

  • 34. Influencing NSAID prescribing in primary care using different feedback strategies.
    Braybrook S; Walker R
    Pharm World Sci; 2000 Apr; 22(2):39-46. PubMed ID: 10849921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Psychotropic Drug Prescribing in the United States: 2014-2015.
    Greenblatt DJ; Harmatz JS; Shader RI
    J Clin Psychopharmacol; 2018 Feb; 38(1):1-4. PubMed ID: 29215384
    [No Abstract]   [Full Text] [Related]  

  • 36. Compliance with quality prescribing indicators in terms of their relationship to financial incentives.
    Fernández Urrusuno R; Montero Balosa MC; Pérez Pérez P; Pascual de la Pisa B
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1845-53. PubMed ID: 23743780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic substitution and therapeutic conservatism as cost-containment strategies in primary care: a study of fundholders and non-fundholders.
    Wilson RP; Hatcher J; Barton S; Walley T
    Br J Gen Pract; 1999 Jun; 49(443):431-5. PubMed ID: 10562740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific therapeutic group age-sex related prescribing units (STAR-PUs): weightings for analysing general practices' prescribing in England.
    Lloyd DC; Harris CM; Roberts DJ
    BMJ; 1995 Oct; 311(7011):991-4. PubMed ID: 7580642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
    Brufsky JW; Ross-Degnan D; Calabrese D; Gao X; Soumerai SB
    Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeat prescribing of medications: A system-centred risk management model for primary care organisations.
    Price J; Man SL; Bartlett S; Taylor K; Dinwoodie M; Bowie P
    J Eval Clin Pract; 2017 Aug; 23(4):779-796. PubMed ID: 28370904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.